OBX-1202

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOBX-1202
Drug Alias NameTrkBR antagonists (Obexia)OBX-1202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 2 inhibitors
TargetsNeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsFeeding and Eating DisordersCachexia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesObexia AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesObexia AG
Active IndicationsN/A
Inactive IndicationsFeeding and Eating DisordersCachexia

Other Information

ATC CodeN/A
Related LinksN/A